Baker Hughes Company stock forecast 2026–2030What is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Analysts' average 12-month price target for Baker Hughes Company is 71.23, 58.9% above the current price of 44.84. Their targets range from 52.00 to 77.00.
Of the 14 firms that rated Baker Hughes Company in the past 12 months, 11 rate it buy or strong buy, 3 hold and 0 sell or strong sell (each firm at its latest rating): a Buy consensus.
Analysts' 1-year price targets range from 52.00 to 77.00, with an average of 71.23.
| Buy | 11 | |
| Hold | 3 | |
| Sell | 0 |
12-month price target
| Highest target | 77.00 |
| Average target | 71.23 |
| Lowest target | 52.00 |
| Current price | 44.84 |
Baker Hughes Company price target historyWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Have analysts recently raised or lowered their Baker Hughes Company price target and rating?
How analysts rate Baker Hughes Company, month by monthWhat is the analyst rating? The analyst rating sums up what the analysts covering a stock recommend, from strong buy to strong sell, by the share of them rating it a buy.
11 of 14 firms rate it buy now, against 17 of 20 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
Baker Hughes Company analyst upgrades, downgrades and price targets
The latest rating change came on 30 October 2026, when Freedom Broker upgraded Baker Hughes Company from Sell to Hold. Its price target is 52.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 30 Oct 2026 | ![]() Freedom BrokerSergey Pigarev | UpgradedSellHold | 52.00 | — | 55.23 |
| 29 Oct 2026 | ReiteratedOverweight | 73.00 → 70.00 | -4.1% | 54.66 | |
| 29 Oct 2026 | ![]() TD Cowen#2745% successMarc Bianchi | ReiteratedBuy | 77.00 | — | 54.51 |
| 19 Oct 2026 | ReiteratedBuy | 72.00 | — | 55.81 | |
| 30 Sept 2026 | ReiteratedNeutral | 72.00 → 69.00 | -4.2% | 55.92 | |
| 29 Sept 2026 | ![]() Goldman Sachs#1050% successNeil Mehta | — | 71.00 | — | 57.12 |
| 29 Sept 2026 | ReiteratedBuy | 80.00 → 77.00 | -3.7% | 57.12 | |
| 14 Sept 2026 | ReiteratedNeutral | 70.00 → 72.00 | +2.9% | 59.06 | |
| 10 Sept 2026 | ![]() UBS#1149% successJosh Silverstein | ReiteratedNeutral | 51.00 → 70.00 | +37.3% | 63.64 |
| 10 Sept 2026 | ![]() Susquehanna#2247% successCharles Minervino | ReiteratedPositive | 72.00 → 75.00 | +4.2% | 63.64 |
| 25 Aug 2026 | ![]() RBC Capital Markets#2346% successKeith Mackey | ReiteratedOutperform | 71.00 → 76.00 | +7.0% | 61.99 |
| 7 Aug 2026 | ![]() Morgan Stanley#1348% successJoe Laetsch | — | 70.00 | — | 62.75 |
| 28 Jul 2026 | ReiteratedNeutral | 71.00 → 51.00 | -28.2% | 58.46 | |
| 28 Jul 2026 | ![]() UBS#1149% successJosh Silverstein | — | 73.00 → 71.00 | -2.7% | 60.11 |
| 28 Jul 2026 | ![]() Susquehanna#2247% successCharles Minervino | ReiteratedPositive | 70.00 → 72.00 | +2.9% | 60.59 |
| 28 Jul 2026 | ![]() Stifel#2546% successStephen Gengaro | ReiteratedBuy | 74.00 → 75.00 | +1.4% | 60.59 |
| 28 Jul 2026 | ReiteratedOverweight | 71.00 → 73.00 | +2.8% | 60.59 | |
| 16 Jul 2026 | ReiteratedEqual Weight | 74.00 → 72.00 | -2.7% | 57.25 | |
| 14 Jul 2026 | ReiteratedOverweight | 64.00 → 71.00 | +10.9% | 57.66 | |
| 8 Jul 2026 | — | 70.00 | — | 56.43 | |
| 8 Jul 2026 | ReiteratedPositive | 80.00 → 70.00 | -12.5% | 54.47 | |
| 8 May 2026 | DowngradedOverweightEqual Weight | — | — | — | |
| 7 May 2026 | ![]() Barclays#2644% successDavid Anderson | — | 62.00 → 74.00 | +19.4% | 66.67 |
| 27 Apr 2026 | ReiteratedPositive | 65.00 → 80.00 | +23.1% | 68.74 | |
| 27 Apr 2026 | ReiteratedNeutral | 54.00 → 73.00 | +35.2% | 68.62 | |
| 27 Apr 2026 | ![]() BMO Capital#2845% successPhillip Jungwirth | ReiteratedOutperform | 65.00 → 80.00 | +23.1% | 68.75 |
| 27 Apr 2026 | ReiteratedOutperform | 57.00 → 71.00 | +24.6% | 69.65 | |
| 27 Apr 2026 | ReiteratedOutperform | 68.00 → 76.00 | +11.8% | 68.94 | |
| 27 Apr 2026 | ![]() Stifel#2546% successStephen Gengaro | ReiteratedBuy | 63.00 → 74.00 | +17.5% | 68.94 |
| 27 Apr 2026 | ReiteratedOverweight | 57.00 → 62.00 | +8.8% | 68.94 | |
| 26 Apr 2026 | — | 67.00 → 80.00 | +19.4% | 68.94 | |
| 15 Apr 2026 | ReiteratedOverweight | 52.00 → 64.00 | +23.1% | 61.49 | |
| 11 Feb 2026 | ![]() Evercore ISI#852% successStephen Richardson | ReiteratedOutperform | 54.00 → 68.00 | +25.9% | 60.51 |
| 2 Feb 2026 | ![]() Stifel#2546% successStephen Gengaro | ReiteratedBuy | 58.00 → 63.00 | +8.6% | 56.04 |
| 31 Jan 2026 | ![]() Jefferies#2945% successLloyd Byrne | — | 58.00 → 67.00 | +15.5% | 56.04 |
| 27 Jan 2026 | ![]() BMO Capital#2845% successPhillip Jungwirth | ReiteratedOutperform | 65.00 | — | 56.29 |
| 27 Jan 2026 | ![]() Industrial Alliance Securities | — | 53.00 → 60.00 | +13.2% | 56.29 |
| 27 Jan 2026 | ReiteratedPositive | 58.00 → 65.00 | +12.1% | 56.29 | |
| 27 Jan 2026 | ![]() Stifel#2546% successStephen Gengaro | ReiteratedBuy | 57.00 → 58.00 | +1.8% | 56.29 |
| 27 Jan 2026 | ReiteratedOverweight | 55.00 → 57.00 | +3.6% | 56.29 | |
| 21 Jan 2026 | ReiteratedBuy | 52.00 → 57.00 | +9.6% | 53.19 | |
| 15 Jan 2026 | ![]() RBC Capital Markets#2346% successKeith Mackey | — | 57.00 | — | 51.59 |
| 7 Jan 2026 | ![]() Susquehanna#2247% successCharles Minervino | ReiteratedPositive | 58.00 | — | 49.61 |
| 12 Dec 2025 | ![]() UBS#1149% successJosh Silverstein | ReiteratedNeutral | 48.00 → 54.00 | +12.5% | 47.23 |
Baker Hughes Company EPS and revenue estimatesWhat are estimate revisions? Estimate revisions are the changes analysts make to their EPS and revenue forecasts for the years ahead. They show whether expectations are rising or falling.
Revenue
EPS
Does Baker Hughes Company beat earnings estimates?What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
On average, analysts' EPS estimate was 13.4% off the result, either way, and their revenue estimate 3.2%, over the last 12 quarters.
- EPS beats
- 88 / 135
- Revenue beats
- 19 / 37
- Average EPS surprise, last 12What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
- +13.4%
- Since
- January 1993
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 27 Oct 2026 | 0.61 | 0.70 | +14.8% | 7.74B | 8.03B | +3.7% |
| Q2 FY2026 | 26 Jul 2026 | 0.50 | 0.64 | +27.5% | 6.52B | 6.74B | +3.4% |
| Q1 FY2026 | 23 Apr 2026 | 0.49 | 0.58 | +17.6% | 6.34B | 6.59B | +3.9% |
| Q4 FY2025 | 25 Jan 2026 | 0.67 | 0.78 | +16.8% | 7.07B | 7.39B | +4.4% |
| Q3 FY2025 | 23 Oct 2025 | 0.62 | 0.68 | +10.4% | 6.83B | 7.01B | +2.6% |
| Q2 FY2025 | 22 Jul 2025 | 0.56 | 0.63 | +13.5% | 6.63B | 6.91B | +4.2% |
| Q1 FY2025 | 22 Apr 2025 | 0.47 | 0.51 | +8.1% | 6.50B | 6.43B | -1.1% |
| Q4 FY2024 | 30 Jan 2025 | 0.62 | 0.70 | +12.2% | 7.07B | 7.36B | +4.2% |
| Q3 FY2024 | 22 Oct 2024 | 0.61 | 0.67 | +9.8% | 7.21B | 6.91B | -4.2% |
| Q2 FY2024 | 25 Jul 2024 | 0.49 | 0.57 | +16.3% | 6.81B | 7.14B | +4.9% |
| Q1 FY2024 | 23 Apr 2024 | 0.40 | 0.43 | +7.5% | 6.37B | 6.42B | +0.7% |
| Q4 FY2023 | 23 Jan 2024 | 0.48 | 0.51 | +6.3% | 6.92B | 6.84B | -1.2% |
Baker Hughes Company stock price 2026–2030: scenariosHow are the stock price scenarios calculated? Bear, base and bull prices for the years ahead: the analysts' EPS estimates times the lowest, average and highest P/E of the stock today and at its last five year ends, or of its peers.
If Baker Hughes Company's earnings keep growing at the 11.2% a year analysts expect to FY2028, it would earn about 4.42 a share in FY2030. At the P/E it has traded at over the last five years (13.7 to 17.7) that is 60.45 to 78.30 a share, or 70.81 at its average P/E of 16.0. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2026 | 2.65 | 36.25 | 42.46 | 46.95 |
| FY2027 | 2.87 | 39.28 | 46.01 | 50.87 |
| FY2028 | 3.58 | 48.89 | 57.27 | 63.32 |
| FY2029 (extrapolated) | 3.98 | 54.36 | 63.68 | 70.41 |
| FY2030 (extrapolated) | 4.42 | 60.45 | 70.81 | 78.30 |
Each year's EPS is the analysts' consensus to FY2028; the years after grow 11.2% a year (the analysts' growth, at most 15%). Bear, base and bull apply the lowest, average and highest P/E of today and the last five fiscal year ends, leaving out any above 60, the mark of a year of collapsed earnings (13.7, 16.0, 17.7).
Most undervalued US stocksHow does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 41.550 | 82.9745Price 41.55168 | +99.7% | |
| 31.540 | 62.7847Price 31.5478 | +99.0% | |
| 1,042.38 | 2,027.06964Price 1,042.382,764 | +94.5% | |
| 79.830 | 152.89115Price 79.83191 | +91.5% | |
| 160.740 | 305.52159Price 160.74396 | +90.1% | |
| 45.990 | 87.1436Price 45.99307 | +89.5% | |
| 430.12 | 788.79592Price 430.12986 | +83.4% |
Furthest below the fair value on each stock's page, updated every day.
















